The influence of endocrine effects of adjuvant therapy on quality of life outcomes in younger breast cancer survivors
- PMID: 16476831
- DOI: 10.1634/theoncologist.11-2-96
The influence of endocrine effects of adjuvant therapy on quality of life outcomes in younger breast cancer survivors
Abstract
Significance: There are 2.2 million breast cancer survivors, and approximately 25%-30% of newly diagnosed women each year are <50 years of age. Adjuvant therapy has prolonged survival, but the quality of that survival is influenced by persistent and late effects of therapy. Knowledge of treatment outcomes will assist in the design of interventions to prevent or manage persistent and late effects in survivors.
Purpose: The purpose of this paper is to review the incidence of gonadal toxicity associated with adjuvant chemotherapy, side effects of endocrine therapy, quality of life outcomes, fertility concerns, and options to preserve fertility in young (<35 years) and young midlife (35-50 years) breast cancer survivors.
Results: Alkylating agent-based chemotherapy causes destruction of primordial follicles and impairment of follicular maturation resulting in temporary preservation of menses, reversible amenorrhea, irregular menses (perimenopause), or irreversible amenorrhea (ovarian failure--menopause). Younger women have a lower risk for amenorrhea with chemotherapy because of sufficient follicular stores, although the gonadal toxicity will result in an earlier than expected menopause. Premature menopause is associated with poorer quality of life, decreased sexual functioning, menopausal symptom distress, psychosocial distress related to fertility concerns, infertility, and uncertainty about late effects of premature menopause. Routine discussion about the menopausal experience, risks for infertility, and fertility preservation options is recommended.
Implications for practice: This review identified adverse treatment outcomes for young and young midlife breast cancer survivors that can be minimized or prevented with targeted interventions.
Similar articles
-
Ovarian function and childbearing issues in breast cancer survivors.Gynecol Endocrinol. 2007 Nov;23(11):625-31. doi: 10.1080/09513590701582406. Gynecol Endocrinol. 2007. PMID: 17926162 Review.
-
The menopausal symptom experience in young mid-life women with breast cancer.Cancer Nurs. 2001 Jun;24(3):201-10; quiz 210-1. Cancer Nurs. 2001. PMID: 11409064
-
Fertility and adjuvant treatment in young women with breast cancer.Breast. 2007 Dec;16 Suppl 2:S175-81. doi: 10.1016/j.breast.2007.07.029. Epub 2007 Sep 4. Breast. 2007. PMID: 17804236 Review.
-
The fertility- and menopause-related information needs of younger women with a diagnosis of breast cancer: a qualitative study.Psychooncology. 2003 Jul-Aug;12(5):500-11. doi: 10.1002/pon.685. Psychooncology. 2003. PMID: 12833562
-
Amenorrhea following chemotherapy for breast cancer: effect on disease-free survival.Oncology (Williston Park). 1994 Dec;8(12):45-52. Oncology (Williston Park). 1994. PMID: 7888312 Review.
Cited by
-
The risk of amenorrhea is related to chemotherapy-induced leucopenia in breast cancer patients receiving epirubicin and taxane based chemotherapy.PLoS One. 2012;7(5):e37249. doi: 10.1371/journal.pone.0037249. Epub 2012 May 16. PLoS One. 2012. PMID: 22615953 Free PMC article.
-
Self-Confidence and Quality of Life in Women Undergoing Treatment for Breast Cancer.Asian Pac J Cancer Prev. 2018 Mar 27;19(3):733-740. doi: 10.22034/APJCP.2018.19.3.733. Asian Pac J Cancer Prev. 2018. PMID: 29582628 Free PMC article.
-
Tendency to breast reconstruction after breast mastectomy among Iranian women with breast cancer.Med J Islam Repub Iran. 2015 Jun 29;29:224. eCollection 2015. Med J Islam Repub Iran. 2015. PMID: 26478882 Free PMC article.
-
Doxorubicin-induced ovarian toxicity.Reprod Biol Endocrinol. 2010 Mar 4;8:20. doi: 10.1186/1477-7827-8-20. Reprod Biol Endocrinol. 2010. PMID: 20202194 Free PMC article.
-
Late endocrine effects of childhood cancer.Nat Rev Endocrinol. 2016 Jun;12(6):319-36. doi: 10.1038/nrendo.2016.45. Epub 2016 Apr 1. Nat Rev Endocrinol. 2016. PMID: 27032982 Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical